The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial of multiple dose VB-111 and weekly paclitaxel in recurrent platinum-resistant Müllerian cancer.
 
Richard T. Penson
Honoraria - AstraZeneca/MedImmune; Endocyte; Genentech/Roche; VBL Therapeutics
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech
Research Funding - Amgen; AstraZeneca/MedImmune; Eisai; Endocyte; VBL Therapeutics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche
 
Suzanne T. Berlin
No Relationships to Disclose
 
Panagiotis Konstantinopoulos
No Relationships to Disclose
 
Carolyn N. Krasner
No Relationships to Disclose
 
Ursula Matulonis
Honoraria - AstraZeneca
Consulting or Advisory Role - Clovis Oncology; Merck KGaA; Momenta Pharmaceuticals
 
Allison Ambrosio
No Relationships to Disclose
 
Daphne Suzin
No Relationships to Disclose
 
Siobhan A Collins
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
 
Yael Chava Cohen
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics